Dogwood Therapeutics, Inc. (DWTX) — Institutional Holders, Q2 2026
15 institutional investment managers reported a DWTX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $6.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DWTX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MILLENNIUM MANAGEMENTNew · +341,814 sh+$550.3K
- BlackRockNew · +28,546 sh+$46.0K
- CITADEL ADVISORSNew · +11,742 sh+$18.9K
- GEODE CAPITAL MANAGEMENTAdded · +8,864 sh+$14.3K
- MORGAN STANLEYNew · +2,222 sh+$3.6K
Biggest sellers
- ARMISTICE CAPITALTrimmed · -147,514 sh-$237.5K
- GOLDMAN SACHS GROUPSold out · -14,598 sh-$23.5K
- MARSHALL WACE, LLPSold out · -11,756 sh-$18.9K
- UBS Group AGTrimmed · -5,225 sh-$8.4K
- Tower Research Capital (TRC)Trimmed · -4,974 sh-$8.0K
DWTX 13F holders ranked 1–15 of 15
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL#1 · 3,132,486 sh | 3,132,486 | $5.0M | 0.06% | -4.5% |
| 2 | MILLENNIUM MANAGEMENT#2 · 341,814 sh | 341,814 | $550.3K | <0.01% | New |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 132,154 sh | 132,154 | $212.8K | 0.00% | 0.0% |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 88,298 sh | 88,298 | $142.2K | 0.00% | +11.2% |
| 5 | VANGUARD FIDUCIARY#5 · 62,736 sh | 62,736 | $101.0K | 0.00% | 0.0% |
| 6 | BlackRock#6 · 28,546 sh | 28,546 | $46.0K | 0.00% | New |
| 7 | NORTHERN#7 · 23,779 sh | 23,779 | $38.3K | 0.00% | 0.0% |
| 8 | CITADEL ADVISORS#8 · 11,742 sh | 11,742 | $18.9K | 0.00% | New |
| 9 | Tower Research Capital (TRC)#9 · 3,093 sh | 3,093 | $5.0K | <0.01% | -61.7% |
| 10 | MORGAN STANLEY#10 · 2,222 sh | 2,222 | $3.6K | 0.00% | New |
| 11 | UBS Group AG#11 · 1,860 sh | 1,860 | $3.0K | 0.00% | -73.7% |
| 12 | JONES FINANCIAL COMPANIES LLLP#12 · 160 sh | 160 | $264.00 | 0.00% | New |
| 13 | BARCLAYS PLC#13 · 157 sh | 157 | $253.00 | 0.00% | New |
| 14 | Activest Wealth Management#14 · 120 sh | 120 | $193.00 | — | 0.0% |
| 15 | GROUP ONE TRADING, L.P.#15 · 9 sh | 9 | $14.00 | 0.00% | 0.0% |
Funds that sold out of DWTX in Q2 2026 (3)
Held DWTX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| GOLDMAN SACHS GROUP14,598 sh | 14,598 | $30.8K |
| MARSHALL WACE, LLP11,756 sh | 11,756 | $24.8K |
| BNP PARIBAS FINANCIAL MARKETS2 sh | 2 | $4.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.